Comments on: Halozyme Therapeutics, Inc. Announces Pricing of Private Offering of $650 Million of Convertible Senior Notes due 2031 and $650 Million of Convertible Senior Notes due 2032

Comments on: Halozyme Therapeutics, Inc. Announces Pricing of Private Offering of $650 Million of Convertible Senior Notes due 2031 and $650 Million of Convertible Senior Notes due 2032 http://ipoedge.com/halozyme-therapeutics-inc-announces-pricing-of-private-offering-of-650-million-of-convertible-senior-notes-due-2031-and-650-million-of-convertible-senior-notes-due-2032/ IPO News & Views Fri, 07 Nov 2025 04:37:00 +0000 hourly 1 https://wordpress.org/?v=6.8.3